Respitab®

A propellant dispersible tablet, an innovative technology for transition to the next generation of pressurised metered dose inhaler. This patented technology is an affordable and cost effective approach for NCE and generic pMDI products, simplifying the manufacturing process for HFC 152a and other propellants.

More info